Abbott: Stroke trials
The registry lists 19 Stroke studies with Abbott as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 3 2Phase 4 2No phase 15(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- AMPLATZER™ LAA Occluder Post Approval Study (PAS)CompletedNCT02964208Results posted
- AMPLATZER™ Cardiac Plug Observational Post-Approval StudyCompletedNCT02954237Results posted
- AMPLATZER™ Amulet™ LAA Occluder TrialCompletedNCT02879448Not applicableResults posted
- Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)CompletedNCT02447081Results posted
- A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With EprosartanCompletedNCT01562613Results posted
- Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid EndarterectomyCompletedNCT01445613Not applicableResults posted
- AMPLATZER Cardiac Plug Clinical TrialCompletedNCT01118299Not applicableResults posted
- Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT TrialCompletedNCT00465270Not applicableResults posted
- Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)TerminatedNCT00106938Not applicableResults posted
- Amulet™ ADVANCE LAAActive, not recruitingNCT05997446
- Amplatzer Amulet LAAO vs. NOACActive, not recruitingNCT04226547Not applicable
- AMPLATZER PFO Occluder Post Approval StudyActive, not recruitingNCT03309332Not applicable
- AMPLATZER Cardiac Plug (ACP) Latin American Post Market ObservationalWithdrawnNCT01962051
- AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up ProtocolCompletedNCT01786486
- PFO ACCESS RegistryNo longer availableNCT00583401
- Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)CompletedNCT00287508Phase 4
- Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOASTCompletedNCT00082251Phase 3
- Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)CompletedNCT00080275Phase 3
- Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELLCompletedNCT00079638Phase 4